Posted by Michael Wonder on 16 Jun 2020
Supreme Court will not hear generic drug price fixing discovery dispute
16 June 2020 - The U.S. Supreme Court on Monday declined to hear generic drug makers’ challenge to a court order requiring them to turn over millions of pages of records to states and drug purchasers accusing them of fixing prices.
Lawyers for drug makers including Teva Pharmaceutical Industries Mylan, Amneal Pharmaceuticals and others had petitioned the Supreme Court to overturn an “extraordinary order” from a district judge requiring the companies to turn over records without reviewing them for relevance first.
